Histogen lives!!! see i told you desmond.

[joel203]

stop selling dreams OP

[Occulus]

If they had anything that worked, they'd have been bought out. That's what so many of you don't understand - if these poorly-capitalized biotech start-ups ever hit gold, they'd be bought by a major pharma. That's when we'll know something that works has been developed, when some tiny bio-tech developing hair protocols are purchased by one of the big players.

[macbeth81]

Source OP?

Below is a link to a Histogen Investor Presentation. If you see the projected revenues for HSC (slide 22), you will see Japan starts in 2018 and US in 2020.

On the last slide it states what the Series D funding will be used for:

• US Phase I for HSC (female)
• Pivotal HSC trial in Asia
• IPO in the TSE or NASDAQ
• Expansion of manufacturing capacity.

Note the pivotal trial in Asia. Therefore another trial is need before release in Asia (Phase II?). Unfortunately, in their Long Promo video (published July), it seems they have not yet completed the Series D funding.

Unless circumstances have changed, I don't see the 2016 launch of HSC in Japan.

Hopefully by 2018 we will have HSC and RepliCel (Shiseido) after all these years waiting. That is at least the current projections by both companies.

https://www.zacksib.com/sites/defaul...uly%202015.pdf

[ShookOnes]

It won't be out in 2016 in Japan that's just what a wishful poster said in one of the threads on this forum.

I wonder what they have to say on congress though, it seems even heavy lawsuits arnt enough to stop them raising funds after court... slightly optimistic.

[Hairmore]

Exited what they will reveal until 2018. It probably means that they are pretty much finished with research and that they will take care of approval and sales now...

[ShookOnes]

Exited what they will reveal until 2018. It probably means that they are pretty much finished with research and that they will take care of approval and sales now...

I think you're thinking of replicel? Histogen has no timeline everyone thought they were dead until recent

[pixels]

I don't think it will be available next year and it doesn't matter anyway because it doesn't grow much hair.

Over 900 posts. How many of them are you repeating yourself?

You have just as much proof that their latest formula doesn't work as we do that it does.

So do us all a favour and only stick with the facts.

[nameless]

Over 900 posts. How many of them are you repeating yourself?

You have just as much proof that their latest formula doesn't work as we do that it does.

So do us all a favour and only stick with the facts.

1 post and it's inane.

I used to back Histogen but their results were disappointing. You need to look over their past results, which are mediocre.

[allTheGoodNamesAreTaken]

It does work though!! There is a presentation that shows clear, cosmetically significant frontal regrowth at 19 weeks, from a single treatment, that is as good as any recovery I have ever seen aside from a hair transplant. I don't know why this is continually ignored, other than possibly because it's on a woman. That's still a working product.

[Arieux]

I agree @allTheGoodNamesAreTaken. Its results are promissing. And in my opinion there is a big possiblity to have Histogen in Japan even before 2018. The one problem is that new hair would be, as far as I know, again susceptible to minaturisation. I was wondering about the theoretical conjuction of those treatments: firstly regrowth from Histogen and then Replicel for maintanance.